Cardiovascular Death Risk in Primary Central Nervous System Lymphoma Patients Treated With Chemotherapy: A Registry-Based Cohort Study

PURPOSE: To study the cardiovascular death (CVD) risk in primary central nervous system lymphoma (PCNSL) patients with chemotherapy. METHODS: We obtained 2,020 PCNSL participants and 88,613 non-central nervous system lymphoma (NCNSL) participants with chemotherapy from Surveillance, Epidemiology, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Tianwang, Qiu, Zicong, Su, Miao, Yang, Jinming, Tang, Yongshi, Jiang, Yanting, Yao, Dunchen, Lai, Yanxian, Li, Yanfang, Liu, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147725/
https://www.ncbi.nlm.nih.gov/pubmed/34046345
http://dx.doi.org/10.3389/fonc.2021.641955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147725/
https://www.ncbi.nlm.nih.gov/pubmed/34046345
http://dx.doi.org/10.3389/fonc.2021.641955

Ejemplares similares